Internal Medicine · Flushing, NY
NPI
1669545166
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13620 38th Ave Ste 6d
Flushing, NY, 11354
Phone (718) 886-8998
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
854 services
Medicare patients, 2024
85
Average age 74
Drug cost, 2024
$4.2M
42,306 prescriptions
Company payments, 2025
$1,808
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hua Ding was code 99213 (office e&m - established), 319 times for 82 patients. In total Hua Ding billed 854 services in 22 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 319 | 82 | $67.31 | $21K |
| 36415 Venipuncture Blood Collection | Office | 107 | 62 | $8.65 | $926 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 59 | 31 | $53.83 | $3,176 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 59 | 59 | $21.51 | $1,269 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 47 | 47 | $21.52 | $1,011 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 44 | 44 | $145.03 | $6,381 |
| G0008 Administration of influenza virus vaccine | Office | 37 | 36 | $36.42 | $1,348 |
| 90662 Vaccine Product | Office | 36 | 35 | $81.00 | $2,916 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 15 | 15 | $12.64 | $190 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 13 | 13 | $184.13 | $2,394 |
| 93000 Electrocardiogram | Office | 12 | 12 | $9.66 | $116 |
| 99214 Office E&M - Established | Office | 11 | 11 | $86.33 | $950 |
By year: 2022 $73K for 1,169 services; 2023 $45K for 785 services; 2024 $46K for 854 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 107 | 62 | $8.65 | $926 |
Medicare prescription drug claims, 2024
In 2024, the drug Hua Ding prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 4,649 prescriptions and refills. In total Hua Ding wrote 42,306 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 4,649 | 5,717 | 678 | $1.6M |
| Losartan Potassium Generic | 3,903 | 5,278 | 529 | $19K |
| Amlodipine Besylate Generic | 3,758 | 5,048 | 503 | $16K |
| Atorvastatin Calcium Generic | 3,344 | 4,506 | 464 | $16K |
| Metformin Hcl Generic | 1,757 | 2,275 | 236 | $5,552 |
| Metoprolol Succinate Generic | 1,600 | 2,153 | 240 | $11K |
| Simvastatin Generic | 1,017 | 1,353 | 134 | $4,878 |
| Rosuvastatin Calcium Generic | 986 | 1,288 | 158 | $5,135 |
| Icosapent Ethyl Generic | 983 | 1,142 | 376 | $143K |
| Levothyroxine Sodium Generic | 974 | 1,397 | 114 | $6,168 |
| Farxiga Dapagliflozin Propanediol | 789 | 931 | 127 | $521K |
| Tamsulosin Hcl Generic | 650 | 853 | 110 | $4,372 |
| Ammonium Lactate Generic | 639 | 756 | 221 | $17K |
| Montelukast Sodium Generic | 587 | 645 | 178 | $2,535 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 577 | 769 | 78 | $4,961 |
Brand drugs: 8,595 claims; generic drugs: 32,938 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hua Ding $1,808 ($1,808 in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $602.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 18 | $602 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $213 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $150 |
| Amgen Inc. AMGN | 1 | $150 |
| Abbvie Inc. ABBV | 7 | $132 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $125 |
| Pfizer Inc. PFE | 4 | $75.96 |
| Esperion Therapeutics, Inc. ESPR | 3 | $54.69 |
| Merck Sharp & Dohme LLC MRK | 2 | $44.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.